Avista Capital Partners
PE / VC
2005
$6 600 M
New York, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Avista invests in leading healthcare companies to drive growth and build lasting value. Our sector focus, operational insights and flexible capital solutions enable us to provide owners, management teams and investors access to opportunity within a dynamic and diverse industry.
Avista is affiliated with Avista Public Acquisition Corp II, a special purpose acquisition company sponsored by Avista to acquire healthcare companies.
Avista focuses on investing in and growing healthcare companies. Our deep industry expertise and proactive value-added investment approach creates enduring partnerships with our portfolio companies.
We were founded in 2005 as a spin-out from DLJ Merchant Banking, which at the time was one of the world's largest and most renowned investment firms. We believe we have built a world-class private equity firm focused on the healthcare industry. Our long tenure in the market leads to a deep understanding of the micro and macro trends driving value and opportunity within the healthcare sector.
Industry
Region of investment
Avista Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Avista Capital Partners II
|
Private Equity (PE)
|
Biotechnology
Consumer Services (B2C)
Healthcare Services
Industrial
Medical Devices
Pharmaceuticals
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1800 M
|
December 2010
|
|
Avista Capital Partners V
|
Private Equity (PE)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$1200 M
|
March 2021
|
|
Avista Healthcare Partners VI
|
Private Equity (PE)
|
Biotechnology
Healthcare Services
Pharmaceuticals
MedTech
Life Sciences
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1500 M
|
March 2024
|
|
Avista Capital Partners, L.P. (Fund I)
|
Private Equity (PE)
|
Healthcare Services
Industrial
Media and Entertainment
Energy
CleanTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$2000 M
|
June 2007
|
